HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

[A preliminary report of microlamellar keratectomy for correction of high myopia].

AbstractOBJECTIVE:
To evaluate the preliminary results of high myopia corrected by microlamellar keratectomy (MLK).
METHODS:
73 eyes of 43 patients with high myopia were treated by MLK. The preoperative refraction ranged from -7.00 to -32.00 D (mean -18.45 +/- 6.18 D). All the operations were performed with a special apparatus made in America for MLK.
RESULTS:
At 6 months after surgery, in the 73 eyes with complete data, all the uncorrected visual acuity and corrected visual acuity were betterthan or equal to their preoperative ones respectively. Uncorrected visual acuity was better than or equal to the preoperative corrected visual acuity in 51 eyes (71.83%). The correction of refraction in 63 eyes (86.30%) was within +/- 4.00 D of the intended correction. No severe complications occurred during and after operation. The postoperative status of refraction was stable.
CONCLUSIONS:
MLK is effective in high myopia treatment and has some special advantages compared with radial keratotomy, photorefractive keratectomy, automated lamellar keratoplasty and excimer laser in situ keratomileusis. But the procedure is influenced by several factors, and the predictability of this procedure is merely fair. The authors suggest that this kind of procedure be done with excellent microsurgery equipment, microsurgical skills and much more clinical experiences in managing corneal disorders.
AuthorsL Xie, L Hu, X Zhang
Journal[Zhonghua yan ke za zhi] Chinese journal of ophthalmology (Zhonghua Yan Ke Za Zhi) Vol. 33 Issue 1 Pg. 12-5 (Jan 1997) ISSN: 0412-4081 [Print] China
PMID10436991 (Publication Type: English Abstract, Journal Article)
Topics
  • Adolescent
  • Adult
  • Cornea (surgery)
  • Female
  • Follow-Up Studies
  • Humans
  • Lasers, Excimer
  • Male
  • Middle Aged
  • Myopia (surgery)
  • Photorefractive Keratectomy (methods)
  • Visual Acuity

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: